Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Sunshine Biopharma (SBFM) Shares Issued (2016 - 2025)

Sunshine Biopharma filings provide 9 years of Shares Issued readings, the most recent being $724500.0 for Q4 2025.

  • On a quarterly basis, Shares Issued fell 55.23% to $724500.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a 34.49% decrease, with the full-year FY2025 number at $2.9 million, down 65.74% from a year prior.
  • Shares Issued hit $724500.0 in Q4 2025 for Sunshine Biopharma, up from -$11418.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $14.4 million in Q1 2022 to a low of -$14.4 million in Q2 2022.
  • Median Shares Issued over the past 4 years was $1.8 million (2024), compared with a mean of $2.6 million.
  • The widest YoY moves for Shares Issued: up 18956000.0% in 2024, down 307.31% in 2024.
  • Sunshine Biopharma's Shares Issued stood at $13.2 million in 2022, then crashed by 30.99% to $9.1 million in 2023, then plummeted by 82.23% to $1.6 million in 2024, then crashed by 55.23% to $724500.0 in 2025.
  • The last three reported values for Shares Issued were $724500.0 (Q4 2025), -$11418.0 (Q2 2025), and $1.6 million (Q4 2024) per Business Quant data.